14841-1 |
Observation |
Prid |
XXX |
Pt |
Nom |
Iron hematoxylin stain |
|
ACTIVE |
Microscopic observation [Identifier] in Specimen by Iron hematoxylin stain |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14841-1 |
|
Iron hematoxylin stain |
|
|
Both |
|
|
|
0 |
IH Stn Spec |
|
|
|
|
|
ID; Identity or presence; IH Stn; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified |
2.78 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Updated to seperate the component from the method; |
0 |
14842-9 |
Observation |
Prid |
XXX |
Pt |
Nom |
Kinyoun iron hematoxylin stain |
|
ACTIVE |
Microscopic observation [Identifier] in Specimen by Kinyoun iron hematoxylin stain |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14842-9 |
|
Kinyoun iron hematoxylin stain |
|
|
Both |
|
|
|
0 |
Kinyoun IH Stn Spec |
|
|
|
|
|
ID; Identity or presence; IH Stn; Infectious Disease; InfectiousDisease; Kinyoun IH Stn; Kinyoun-hematoxylin stain; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified |
2.78 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Updated to seperate the component from the method; |
0 |
14843-7 |
6-Monoacetylmorphine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14843-7 |
|
|
|
|
Both |
|
|
|
0 |
6MAM Gast Ql |
|
|
|
|
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
14844-5 |
6-Monoacetylmorphine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14844-5 |
|
|
|
|
Both |
|
|
|
0 |
6MAM SerPl Ql |
|
|
|
|
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
14845-2 |
6-Monoacetylmorphine |
ACnc |
Urine |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Monoacetylmorphine [Presence] in Urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14845-2 |
|
|
|
|
|
|
|
|
0 |
Deprecated 6MAM Ur Ql |
|
|
|
|
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Arbitrary Concentration; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; Ql; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.4 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
14846-0 |
N-acetylprocainamide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
N-acetylprocainamide [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14846-0 |
|
|
|
|
Both |
|
|
|
0 |
NAPA SerPl-sCnc |
|
|
|
Y |
|
Acecainide; Acetylprocanam; DRUG/TOXICOLOGY; Drugs; Level; NAPA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14847-8 |
Neutrophils/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Neutrophils/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14847-8 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Neutrophils NFr Pcar Manual |
|
|
|
Y |
|
Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Pcar; Percent; Pericardial fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
14848-6 |
Neutrophils/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Neutrophils/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14848-6 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Neutrophils NFr Plr Manual |
|
|
|
Y |
|
HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; Pleural; Pleural fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
14849-4 |
Nitrazepam |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Nitrazepam [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14849-4 |
|
|
|
|
Both |
|
|
|
0 |
Nitrazepam SerPl-sCnc |
|
|
|
Y |
|
Alodorm; APODORM; AREM; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Level; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somnibel n; Somniper; Somnite; SR; Substance concentration; Surem |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
1485-2 |
Gastrin^15M post 0.2 U/kg secretin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
1485-2 |
|
|
|
|
Observation |
|
|
|
0 |
Gastrin 15M p 0.2 U/kg SCT SerPl-mCnc |
|
|
|
Y |
|
15M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome |
2.34 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
14850-2 |
Nitrazepam |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Nitrazepam [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14850-2 |
|
|
|
|
Both |
|
|
|
0 |
Nitrazepam Ur-sCnc |
|
|
|
Y |
|
Alodorm; APODORM; AREM; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Level; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; Somnibel n; Somniper; Somnite; Substance concentration; Surem; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14851-0 |
Norclozapine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Norclozapine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14851-0 |
|
|
|
|
Both |
|
|
|
0 |
Norclozapine SerPl-sCnc |
|
|
|
Y |
|
Clozapine metabolite; Desmethylclozapine; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14852-8 |
Norepinephrine |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Norepinephrine [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14852-8 |
|
|
|
|
Both |
|
|
|
0 |
Norepineph Plas-sCnc |
|
|
|
Y |
|
Chemistry; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14853-6 |
Norepinephrine |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Norepinephrine [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14853-6 |
|
|
|
|
Both |
|
|
|
0 |
Norepineph Ur-sCnc |
|
|
|
Y |
|
Chemistry; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14854-4 |
Norepinephrine |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Norepinephrine [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
14854-4 |
|
|
|
|
Both |
|
|
|
0 |
Norepineph 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
14855-1 |
Norfluoxetine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Norfluoxetine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14855-1 |
|
|
|
|
Both |
|
|
|
0 |
Norfluoxetine SerPl-sCnc |
|
|
|
Y |
|
(S)-Norfluoxetine; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Level; Norfluoxetin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Seproxetine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14856-9 |
Nortriptyline |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Nortriptyline [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14856-9 |
|
|
|
|
Both |
|
|
|
0 |
Nortrip SerPl-sCnc |
|
|
|
Y |
|
Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; Level; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14857-7 |
Leukocytes other/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14857-7 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
WBC Other NFr Pcar Manual |
|
|
|
Y |
|
Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; PCAR; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
14858-5 |
Leukocytes other/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14858-5 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
WBC Other NFr Plr Manual |
|
|
|
Y |
|
HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
14859-3 |
Leukocytes other/Leukocytes |
NFr |
Periton fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other/Leukocytes in Peritoneal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14859-3 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
WBC Other NFr Prt Manual |
|
|
|
Y |
|
Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
1486-0 |
Gastrin^20M post 0.2 U/kg secretin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
1486-0 |
|
|
|
|
Observation |
|
|
|
0 |
Gastrin 20M p 0.2 U/kg SCT SerPl-mCnc |
|
|
|
Y |
|
20M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome |
2.34 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
14860-1 |
Leukocytes other/Leukocytes |
NFr |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other/Leukocytes in Synovial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14860-1 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
WBC Other NFr Snv Manual |
|
|
|
Y |
|
HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
14861-9 |
Oxalate |
PrThr |
Calculus |
Pt |
Ord |
|
|
ACTIVE |
Oxalate [Presence] in Stone |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14861-9 |
|
|
|
|
Observation |
|
|
|
0 |
Oxalate Stone Ql |
|
|
|
|
|
Calc; Calculi; Chemistry; Ethanedioate; Ethanedioic acid; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Oxal; Oxalic acid; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
14862-7 |
Oxalate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Oxalate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
14862-7 |
|
|
|
|
Both |
|
|
|
0 |
Oxalate 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Ethanedioate; Ethanedioic acid; Kidney; Nephrology; Oxal; Oxalic acid; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
14863-5 |
oxyCODONE |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
oxyCODONE [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14863-5 |
|
|
|
|
Both |
|
|
|
0 |
oxyCODONE Gast Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Vicodin |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |